News
DGAP-News: Exasol publishes audited consolidated financial statements 2021 and results for Q1 2022
DGAP-News: Energiekontor AG: Wind farm project Vettweiss-Müddersheim sold to Danish investor
DGAP-News: Deutsche Familienversicherung reaches profit zone with 37% growth
DGAP-News: DEFENCE’S NOVEL ACCUVAC-PTE7 VACCINE SHOWS COMPLETE PROTECTION FROM CERVICAL CANCER
DGAP-News: Dermapharm Holding SE: excellent start into financial year 2022
Orascom Development Holding AG: records a net profit of CHF 17.5 million, an increase of 464.5% compared to same period last year.
SIG Group AG: SIG raises c. EUR 204 million to partially finance the acquisitions of Scholle IPN and Evergreen Asia
Kuros Biosciences announces commercial launch of MagnetOs Easypack Putty in the U.S.
Publication of Annual Report 2021/2022 and Invitation to the Ordinary Shareholders’ Meeting
Institutional Property Advisors Closes Sale of $96 Million Downtown Tempe Multifamily Asset
Institutional Property Advisors (IPA), a division of Marcus & Millichap (NYSE:MMI), announced the sale of Hudson on Farmer, a 171-unit boutique apartment asset in Downtown Tempe, Arizona. The
Fluor Issues Statement Regarding Recent Decision on Pantex Plant and Y-12 National Security Complex Contract Award
Fluor Corporation (NYSE: FLR) announced today that the National Nuclear Security Administration’s (NNSA) shift in strategy related to the combined management and operation of the Pantex Plant and
Nutrien Announces Results of 2022 Annual Meeting
Nutrien Ltd (TSX and NYSE: NTR) announced today the results of its annual meeting of shareholders held on May 17, 2022 (the “Meeting”). A total of 431,009,629 common shares, representing 78.01% of
Granite REIT Declares Distribution for May 2022
Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.2583 per stapled unit for the month of
Ted Pick to Speak at the Bernstein Strategic Decisions Conference
Ted Pick, Co-President, Head of Institutional Securities and Co-Head of Corporate Strategy at Morgan Stanley, will speak at the Bernstein Strategic Decisions Conference on Wednesday, June 1, 2022
LiveRamp to Discuss Fourth Quarter and Fiscal Year Results
LiveRamp® (NYSE: RAMP), the leading global data enablement platform, today announced that its fiscal year 2022 fourth quarter and full year earnings release is expected to be issued on Tuesday, May
Cushman & Wakefield Acquires Leading Team from Cresa Partners of Los Angeles, Inc.
Cushman & Wakefield (NYSE: CWK) announced the firm has acquired Cresa Partners of Los Angeles, Inc. (“Cresa”). Cresa’s operations comprise three Los Angeles County offices located in West Los
NANOBIOTIX to Present During the Jefferies Healthcare Conference in June 2022
Regulatory News:
NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities
Insight to Present at the 50th Annual J.P. Morgan Global Technology, Media and Communications Conference
Insight Enterprises, Inc. (Nasdaq: NSIT) (the “Company”) today announced that it is scheduled to participate in the following upcoming investor conference:
50th Annual J.P. Morgan Global
Keysight Technologies Reports Second Quarter 2022 Results
Keysight Technologies, Inc. (NYSE: KEYS) today reported financial results for the second fiscal quarter ended April 30, 2022.
"The Keysight team delivered another strong quarter, exceeding the
Savara to Present at H.C. Wainwright Global Investment Conference
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the H.C. Wainwright Global
Piper Sandler Advises PETRONAS Chemicals Group Berhad on Acquisition of Perstorp
Piper Sandler & Co. chemicals investment banking announced today that it has advised PETRONAS Chemicals Group Berhad (PCG) on its acquisition of Perstorp Holding AB. The transaction Enterprise
Poxel Provides Corporate Update and Reports Cash and Revenue for the First Quarter 2022
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
Transgene Announces Upcoming Investor Meetings
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces that Management will
Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the U.S. Food and Drug Administration (FDA) expanded emergency use authorization (EUA) to include a booster dose after